Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer-Reference-Cited by-同舟云学术

Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer

Published:2018-02-23 Issue:5 Volume:93 Page:664-671
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Streiff Michael B.¹^ORCID,Milentijevic Dejan²^ORCID,McCrae Keith³,Yannicelli Daniel⁴,Fortier Jonathan⁵,Nelson Winnie W.²,Laliberté François⁵,Crivera Concetta²,Lefebvre Patrick⁵,Schein Jeff²,Khorana Alok A.³

Affiliation:

1. Johns Hopkins University School of Medicine; Baltimore Maryland

2. Janssen Scientific Affairs, LLC; Raritan New Jersey

3. Taussig Cancer Institute, Cleveland Clinic; Cleveland Ohio

4. Janssen Pharmaceuticals, Inc.; Raritan New Jersey

5. Groupe d'analyse, Ltée; Montréal Québec Canada

Funder

Janssen Scientific Affairs, LLC.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25059/fullpdf

Reference25 articles.

1. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy;Khorana;J Thromb Haemost.,2007

2. Venous thromboembolism and cancer: risks and outcomes;Lee;Circulation.,2003

3. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study;Heit;Arch Intern Med.,2000

4. New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients;Gerotziafas;Ther Clin Risk Manag.,2014

5. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;Prandoni;Blood.,2002

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing;Clinical and Translational Oncology;2024-09-14

2. Bleeding Risk in Patients with Cancer;Hämostaseologie;2024-09-03

3. Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis;Journal of Pharmaceutical Policy and Practice;2024-07-17

4. Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study;Journal of Thrombosis and Thrombolysis;2024-05-12

5. Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer;JAMA;2023-06-13